Through bioinformatics, we predicted DNMT3a as a common target gene of miR-340-5p, miR-143-3p, and miR-145-5p, which was further validated by our following dual-luciferase reporter assay combined with transfecting prostate cancer cell with miRNA mimics and inhibitors. Here, DNMT3A is linked to prostate carcinoma.